Status:
ACTIVE_NOT_RECRUITING
Integrated HPV Vaccination and Adolescent Health in Tanzania
Lead Sponsor:
Jhpiego
Conditions:
Integrated Care
Adolescent
Eligibility:
All Genders
9+ years
Phase:
NA
Brief Summary
Background: Cervical cancer is a serious global public health problem, particularly in sub-Saharan Africa, where it is the leading cause of cancer in women, with around 70,722 new cases each year. Vac...
Eligibility Criteria
Inclusion
- Adolescents: Age: 9 to 15; Residence in the study regions; Parental or guardian permission is required; Provides assent and agrees to participate in the study.
- Parents/caregivers: Be the parent or legal guardian of an adolescent aged 9 to 15 years; Residence in the study regions; Provides informed consent and agrees to participate in the study.
Exclusion
- People who have time constraints; participants who have medical conditions that make them unable to participate; those residing outside study health regions; those who do not provide consent/assent to participate.
Key Trial Info
Start Date :
May 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06915844
Start Date
May 22 2025
End Date
December 1 2025
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Muhimbili University of Health and Allied Sciences (MUHAS)
Dar es Salaam, Tanzania